FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. GNK
6. HTFL
7. SNDK
8. DVLT
9. ADYYF
10. WDAY

Go back to FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

Novavax's (NVAX) Covid-19 Vaccine Approval in the U.S. Could Be Delayed - CNBC

June 9, 2022 10:16 AM EDT

The U.S. Food and Drug Administration's (FDA) decision on Novavax's (NASDAQ: NVAX) Covid-19 vaccine could be delayed, according to a report by CNBC.

An FDA spokesperson told CNBC that the regulatory body will have to review modifications to the drugmakers... More